Zweers et al. found that reduced tenascin-X serum levels were only present in 5–10% of patients diagnosed with Benign Joint Hypermobility Syndrome, or hEDS [59]. This evidence concerns the gene TNXB and Ehlers-Danlos syndrome, hypermobility type.